isoproterenol has been researched along with etorphine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Devi, LA; Gomes, I; Jordan, BA; Nivarthi, R; Trapaidze, N | 1 |
Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
2 other study(ies) available for isoproterenol and etorphine
Article | Year |
---|---|
Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Animals; Cell Line; Cyclic AMP; Dimerization; Dose-Response Relationship, Drug; Endocytosis; Enzyme Activation; Etorphine; Heterotrimeric GTP-Binding Proteins; Humans; Isoproterenol; Ligands; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Narcotics; Phosphatidylethanolamines; Phosphorylation; Precipitin Tests; Protein Transport; Receptor Aggregation; Receptors, Adrenergic, beta-2; Receptors, Opioid; Recombinant Fusion Proteins; Transfection | 2001 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |